Improving detection of colorectal cancer

Practitioner

Volumn 254, Issue 1733, 2010, Pages 17-21

  Orbell, James ^a   West, Nicholas J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER STAGING; COLORECTAL TUMOR; EARLY DIAGNOSIS; HUMAN; METHODOLOGY; PATIENT REFERRAL; REVIEW; RISK FACTOR;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; NEOPLASM STAGING; REFERRAL AND CONSULTATION; RISK FACTORS;

EID: 79952663898     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. UK Bowel Cancer Statistics, www.cancerresearchuk.org, 2006.
2. Department of Health. Referral guidelines for suspected cancer. DoH. London., 2000.
3. National Institute for Health and Clinical Excellence. Referral guidelines for suspected cancer. NICE. London.2005
4. Thorne K, Hutchings HA, Elwyn G. The effects of the two-week rule on NHS colorectal cancer diagnostic services: a systematic literature review. BMC Health Serv Res 2006;6:43
5. Winawer SJ. Natural history of colorectal cancer. Am J Med 1999;106(1A):3S-6S; discussion 50S-1S (Pubitemid 29100862)
6. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112(2):594-642 (Pubitemid 27078848)
7. Scholefield JH. ABC of colorectal cancer: screening. BMJ 2000;321(7267):1004-6
8. Font A, Abad A, Monzo M et al. Prognostic value of Kras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer. Dis Colon Rectum 2001;44(4):549-57 (Pubitemid 32336428)
9. Norat T, Bingham S, Ferrari P et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition, J Natl Cancer Inst, 15,97,(12), 609-16. (Pubitemid 41417942)
10. Howe GR, Benito E, Castelleto R et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case control studies. J Natl Cancer Inst 1992;16;84(24):1887-96 (Pubitemid 23004616)
11. Thornalley P. More good things in vegetables than you ever imagined. Biochemistry 1999;21:19-23
12. Bergstrom A, Pisani P, Tenet V et al. Overweight as an avoidable cause of cancer in Europe, Int J Cancer, 2001, 94,(3), 421-30. (Pubitemid 32049639)
13. Cho E, Smith-Warner SA, Ritz J et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies, Ann Intern Med, 2004, 140, 603-13.
14. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut 2001, 48 (4), 526-35. (Pubitemid 32234798)
15. Cunningham D, Atkin W, Lenz HJ et al. Colorectal cancer, Lancet 2010, 375,(9719) 1030-47.
16. Flashman K, O'Leary DP, Senapati A et al. The Department of Health's "two week standard" for bowel cancer: is it working? Gut 2004;53(3):387-91
17. Shallow TA, Wagner FB, Jr, Colcher RE. Clinical evaluation of 750 patients with colon cancer; diagnostic survey and follow-up covering a fifteen-year period. Ann Surg 1955;142(2):164-75
18. Thompson MR, Perera R, Senapati A et al. Predictive value of common symptom combinations in diagnosing colorectal cancer. Br J Surg 2007;94(10):1260-5
19. McSherry CK, Cornell GN, Glenn F. Carcinoma of the colon and rectum, Ann Surg 1969, 169, (4) 502-9
20. Association of Coloproctologists of Great Britain and Ireland. Guidelines for the Management of Colorectal Cancer. 3rd edition. 2007
21. Martling AL, Holm T, Rutqvist LE et al. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356(9224):93-6 (Pubitemid 30438509)
22. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer, Br J Surg 2004, 91 (5) 610-17 (Pubitemid 38624671)
23. Sebag-Montefiore D, Stephens RJ, Steele R et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet2009;373(9666):811-20
24. National Institute for Health and Clinical Excellence. Guidance on cancer services: Improving outcomes in colorectal cancer. Manual update. NICE. London. 2004
25. Andre T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer, N Engl J Med 2004 350 (23) 2343-51. (Pubitemid 38702845)
26. Wolmark N, Colangelo L, Wieand S. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer, Semin Oncol 2001 25, Suppl 1, 9-13 (Pubitemid 32173098)
27. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials, Lancet 2001, 358, (9290) 1291-304
28. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990;77(11):1241-6
29. Garden OJ, Rees M, Poston GJ et al. Guidelines for resection of colorectal cancer liver metastases. Gut 2006;55 Suppl 3:iii1-8 (Pubitemid 44085662)
30. West NJ, Poullis AP, Leicester RJ. The NHS Bowel Cancer Screening Programme - a realistic approach with additional benefits, Colorectal Dis 2008, 10 (7) 708-14.
31. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer, N Engl J Med 2000, 343 (22) 1603-07 (Pubitemid 32162983)
32. Atkin WA, Edwards R, Kralj-Hans I et al. UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial, Lancet 2010, 375 1624-33.